Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zygote ; 5(2): 153-75, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9276512

RESUMO

We address the developmental activation, in the zebrafish embryo, of intrinsic cell-cycle checkpoints which monitor the DNA replication process and progression through the cell cycle. Eukaryotic DNA replication is probably carried out by a multiprotein complex containing numerous enzymes and accessory factors that act in concert to effect processive DNA synthesis (Applegren, N. et al. (1995) J. Cell. Biochem. 59, 91-107). We have exposed early zebrafish embryos to three chemical agents which are predicted to specifically inhibit the DNA polymerase alpha, topoisomerase I and topoisomerase II components of the DNA replication complex. We present four findings: (1) Before mid-blastula transition (MBT) an inhibition of DNA synthesis does not block cells from attempting to proceed through mitosis, implying the lack of functional checkpoints. (2) After MBT, the embryo displays two distinct modes of intrinsic checkpoint operation. One mode is a rapid and complete stop of cell division, and the other is an 'adaptive' response in which the cell cycle continues to operate, perhaps in a 'repair' mode, to generate daughter nuclei with few visible defects. (3) The embryo does not display a maximal capability for the 'adaptive' response until several hours after MBT, which is consistent with a slow transcriptional control mechanism for checkpoint activation. (4) The slow activation of checkpoints at MBT provides a window of time during which inhibitors of DNA synthesis will induce cytogenetic lesions without killing the embryo. This could be useful in the design of a deletion-mutagenesis strategy.


Assuntos
Blastocisto/efeitos dos fármacos , Blastocisto/fisiologia , Ciclo Celular/efeitos dos fármacos , Replicação do DNA/efeitos dos fármacos , Embrião não Mamífero/efeitos dos fármacos , Animais , Afidicolina/farmacologia , Camptotecina/farmacologia , Etoposídeo/farmacologia , Deleção de Genes , Mutagênese , Fatores de Tempo , Peixe-Zebra
2.
Biochem Cell Biol ; 75(5): 535-50, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9551178

RESUMO

We describe a rapid and sensitive method for high-resolution imaging at the cellular and subcellular levels in the whole-mount zebrafish embryo. The procedure involves fixing and staining the embryo, followed by deyolking and flattening it under a cover slip, to produce a planar mount that is 20 to 100 microns thick. Such a flattened whole mount allows imaging with a spatial resolution of approximately 500 nm in the x-y plane and does not require the use of embedding, sectioning, confocal microscopy, or computational deblurring procedures. We can resolve all individual nuclei and chromosome sets in the embryo, up to the late gastrula stage (10,000 cell stage). In addition, older embryos (through the segmentation stage) can also be examined, with the preservation of significant morphological detail. Because of its ability to resolve subcellular detail, the flattened whole-mount method can provide significant biological information beyond what can be obtained from conventional (three-dimensional) whole mounts. We have used the flattened whole-mount method to study subcellular events related to progression through the cell cycle or to apoptosis, in cells of the early zebrafish embryo. A specific DNA-binding dye (Hoechst 33258) or an antibody against a chromosomal protein (histone H1) was used to stain the nuclei of individual cells in the embryo. This allowed us to determine the spatial positions of all the individual cells, and also their stages in the cell cycle. A terminal transferase (TUNEL) assay was used to detect apoptotic cells. This combination of specific stains allowed us to study the behaviors of groups of cells in situ, within the developing zebrafish embryo.


Assuntos
Microscopia de Fluorescência/métodos , Coloração e Rotulagem/métodos , Peixe-Zebra/embriologia , Animais , Ciclo Celular , Núcleo Celular , Cromossomos , DNA , Fragmentação do DNA , Embrião não Mamífero/citologia , Corantes Fluorescentes , Histonas , Técnicas Imunoenzimáticas , Sensibilidade e Especificidade
3.
Zygote ; 5(4): 329-50, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9563681

RESUMO

We have studied the developmental activation of the metaphase checkpoint, and the consequences of activating this checkpoint, in the zebrafish embryo. (1) Treatment with nocodazole (a microtubule destabiliser) before mid-blastula transition (MBT) produces complete destruction of all nuclei in the deep cell layer of the embryo. In contrast, nocodazole treatment after MBT efficiently produces metaphase arrest in this cell layer. Thus, the metaphase checkpoint becomes activated at MBT. (2) Although a metaphase arrest is induced by nocodazole, it is not induced by paclitaxel (a microtubule stabiliser). Thus the metaphase checkpoint appears to sense a destabilisation, but not a stabilisation, of spindle microtubules. (3) Metaphase-arrested cells (in nocodazole) can be driven into the next interphase by adding the Ca2+-specific ionophore A23187. Thus, a Ca2+-signalling pathway lies downstream of, or parallel to, the metaphase checkpoint. (4) After mid-gastrula stage, treatment with nocodazole produces DNA fragmentation in all three cell layers. In the enveloping epithelial monolayer (EVL), this is associated with a classical apoptotic phenotype. In the deep layer, it is associated with an unusual, highly condensed nuclear state that is entered directly from metaphase arrest. Thus, after the mid-gastrula stage, the embryo responds to nocodazle by undergoing apoptosis. (5) Nocodazole-induced apoptosis in the deep cell layer can be blocked by the caspase-1,4,5 inhibitors Ac-YVAD-CHO and Ac-YVAD-CMK. This suggests that a homologue of the C. elegans ced-9-ced-4-ced-3 pathway is involved in control over apoptosis in the early zebrafish embryo.


Assuntos
Apoptose/efeitos dos fármacos , Blastocisto/efeitos dos fármacos , Metáfase/efeitos dos fármacos , Nocodazol/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2 , Peixe-Zebra/embriologia , Clorometilcetonas de Aminoácidos/farmacologia , Animais , Blastocisto/citologia , Calcimicina/farmacologia , Núcleo Celular/efeitos dos fármacos , Fase de Clivagem do Zigoto/efeitos dos fármacos , Inibidores de Cisteína Proteinase/farmacologia , Fragmentação do DNA/efeitos dos fármacos , Células Epiteliais , Gástrula/citologia , Gástrula/efeitos dos fármacos , Genes bcl-2/genética , Ionóforos/farmacologia , Microtúbulos/efeitos dos fármacos , Oligopeptídeos/farmacologia , Paclitaxel/farmacologia , Proteínas Proto-Oncogênicas/genética , RNA Mensageiro/análise , Transdução de Sinais/fisiologia , Fuso Acromático/efeitos dos fármacos , Proteína X Associada a bcl-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...